<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="helma.xsl"?>
<xmlroot xmlns:hop="http://www.helma.org/docs/guide/features/database">
  <hopobject id="2432" name="Page" prototype="Page" created="1363280116832" lastModified="1542876583642">
  <hop:parent idref="0" prototyperef="Root"/>
    <http_browser>Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)</http_browser>
    <lang>en-us</lang>
    <uri>bone-update</uri>
    <http_host>127.0.0.1:8080</http_host>
    <time type="date">22.11.2018 08:49:43 UTC</time>
    <pseudoparent idref="0" prototyperef="Root"/>
    <http_remotehost>127.0.0.1</http_remotehost>
    <hopsession>127.0.0.1w8rfidjo93g9</hopsession>
    <user>default</user>
    <pvcount type="float">85.0</pvcount>
    <body>We work together &lt;a href=&quot;https://digital-matchbox.com/ceftin-antibiotic-webmd-5522.pdf#display&quot;&gt;ceftin antibiotic webmd&lt;/a&gt;  Fitch previously assumed that Finmeccanica would complete asset disposals of up to EUR1bn by early 2013, the proceeds of which were to be applied to net debt reduction. To date, only the 15% stake in aero engine parts maker, AVIO SpA, has been announced, which will bring in around EUR260m of proceeds. Whilst it is still possible that the company will complete the sales of targeted assets, the on-going delays in this process mean that the anticipated improvement in the company&apos;s leverage position will not materialise in the expected time frame in order for the company to maintain an investment grade rating.
 </body>
    <http_language>en-US,en;q=0.8</http_language>
    <is_xhtml type="boolean">true</is_xhtml>
    <http_referer>http://beagleboard.org/bone-update/edit</http_referer>
  </hopobject>
</xmlroot>
